All Wellcome articles
-
News
Genomic surveillance needed to help fight antimicrobial resistance
An international group of researchers is calling for the potential of genomic surveillance to be harnessed to tackle antimicrobial resistance (AMR), a major global challenge.
-
News
Biovac signs deal with IVI to deliver oral cholera vaccine for African and global markets
South African based Bio-pharmaceutical company Biovac has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV).